Novo Nordisk A S
NVO
Revenue
290.40B
▲58.14B▲25.03%
12 Months ChangeAssets
465.80B
▲151.31B▲48.11%
12 Months ChangeLiabilities
322.31B
▲114.38B▲55.01%
12 Months ChangeFree Cash Flow
73.80B
▼-9.30B▼-11.19%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-01-31
Form 20-F
ID: 0001628280-24-002635
2023-02-01
Form 20-F
ID: 0001628280-23-001868
2022-02-02
Form 20-F
ID: 0001628280-22-001639
2021-02-03
Form 20-F
ID: 0001628280-21-001364
2020-02-05
Form 20-F
ID: 0001628280-20-001021
2019-02-04
Form 20-F
ID: 0001628280-19-000875
2018-02-08
Form 20-F
ID: 0001628280-18-001266
2017-02-09
Form 20-F
ID: 0001171843-17-000780
2016-02-10
Form 20-F
ID: 0001171843-16-007795
2015-02-05
Form 20-F
ID: 0001171843-15-000625